• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多参数磁共振成像对纤维化、脂肪变性和肝脏铁沉积进行诊断和定量分析。

Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging.

作者信息

Stoopen-Rometti M, Encinas-Escobar E R, Ramirez-Carmona C R, Wolpert-Barraza E, Kimura-Hayama E, Sosa-Lozano L A, Favila R, Kimura-Fujikami Y, Saavedra-Abril J A, Loaeza-Del Castillo A

机构信息

Departamento de Imagen, C.T. Scanner Lomas Altas, Ciudad de México, México.

Curso Universitario de Radiología, C.T. Scanner, Instituto Nacional de Cardiología Ignacio Chávez, Universidad Nacional Autónoma de México, Ciudad de México, México.

出版信息

Rev Gastroenterol Mex. 2017 Jan-Mar;82(1):32-45. doi: 10.1016/j.rgmx.2016.06.001. Epub 2017 Jan 12.

DOI:10.1016/j.rgmx.2016.06.001
PMID:28089429
Abstract

BACKGROUND

The presence of liver fibrosis is the common denominator in numerous chronic liver diseases that can progress to fibrosis and hepatocellular carcinoma. Most important, with respect to frequency, are viral hepatitis and non-alcoholic fatty liver disease, the prevalence of which is increasing in epidemic proportions. Liver biopsy, albeit imperfect, continues to be the criterion standard, but in many clinical situations tends to be replaced with noninvasive imaging methods.

OBJECTIVES

The aim of the present article was to describe our imaging department experience with magnetic resonance elastography and to analyze and discuss recently published results in gastroenterology, hepatology, and radiology from other authors in the literature, complemented with a PubMed search covering the last 10 years.

RESULTS AND CONCLUSIONS

Magnetic resonance elastography is an efficacious, noninvasive method with results that are concordant with liver biopsy. It is superior to ultrasound elastography because it evaluates a much greater volume of hepatic tissue and shows the often heterogeneous lesion distribution. The greatest advantage of the magnetic resonance protocol described is the fact that it quantifies fibrosis, fat content, and iron content in the same 25min examination specifically directed for that purpose, resulting in a favorable cost-benefit ratio for the patient and/or institution.

摘要

背景

肝纤维化的存在是众多慢性肝病的共同特征,这些慢性肝病可进展为纤维化和肝细胞癌。就发病率而言,最重要的是病毒性肝炎和非酒精性脂肪性肝病,其患病率正呈流行比例上升。肝活检尽管并不完美,但仍然是标准准则,但在许多临床情况下,它往往被非侵入性成像方法所取代。

目的

本文旨在描述我们影像科在磁共振弹性成像方面的经验,并分析和讨论文献中其他作者最近在胃肠病学、肝病学和放射学方面发表的结果,并辅以过去10年的PubMed搜索。

结果与结论

磁共振弹性成像是一种有效的非侵入性方法,其结果与肝活检结果一致。它优于超声弹性成像,因为它评估的肝组织体积大得多,并且显示出病变分布通常不均匀。所描述的磁共振检查方案的最大优点是,它可以在专门为此目的进行的25分钟检查中同时量化纤维化、脂肪含量和铁含量,从而为患者和/或机构带来良好的成本效益比。

相似文献

1
Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging.通过多参数磁共振成像对纤维化、脂肪变性和肝脏铁沉积进行诊断和定量分析。
Rev Gastroenterol Mex. 2017 Jan-Mar;82(1):32-45. doi: 10.1016/j.rgmx.2016.06.001. Epub 2017 Jan 12.
2
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?弹性成像能否区分单纯性脂肪肝与非酒精性脂肪性肝炎?
Semin Liver Dis. 2018 Feb;38(1):14-20. doi: 10.1055/s-0037-1618587. Epub 2018 Feb 22.
3
Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).磁共振成像和瞬时弹性成像在非酒精性脂肪性肝病(NAFLD)管理中的应用
Expert Rev Clin Pharmacol. 2017 Apr;10(4):379-390. doi: 10.1080/17512433.2017.1299573. Epub 2017 Mar 9.
4
Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease.多参数磁共振成像/磁共振弹性成像评估酒精相关性肝病中脂肪变性、炎症和纤维化的进展和消退。
Alcohol Clin Exp Res. 2021 Oct;45(10):2103-2117. doi: 10.1111/acer.14699. Epub 2021 Sep 5.
5
Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.放射影像学在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的应用。
Clin Liver Dis. 2018 Feb;22(1):93-108. doi: 10.1016/j.cld.2017.08.005. Epub 2017 Oct 10.
6
Magnetic resonance elastography in the diagnosis of hepatic fibrosis.磁共振弹性成像在肝纤维化诊断中的应用
Semin Ultrasound CT MR. 2013 Feb;34(1):81-8. doi: 10.1053/j.sult.2012.11.007.
7
Liver fibrosis: Review of current imaging and MRI quantification techniques.肝纤维化:当前影像学及磁共振成像定量技术综述
J Magn Reson Imaging. 2017 May;45(5):1276-1295. doi: 10.1002/jmri.25550. Epub 2016 Dec 16.
8
Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.评估脂肪变性和纤维化:声学结构定量与现有技术的比较。
World J Gastroenterol. 2015 Apr 28;21(16):4894-902. doi: 10.3748/wjg.v21.i16.4894.
9
Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging.使用非侵入性瞬时弹性成像和多参数磁共振成像对疑似非酒精性脂肪性肝病患者诊断途径的决策分析模型
BMJ Open. 2016 Sep 20;6(9):e010507. doi: 10.1136/bmjopen-2015-010507.
10
Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions.磁共振弹性成像及其他磁共振成像技术在慢性肝病中的应用:现状与未来方向
Gut Liver. 2016 Sep 15;10(5):672-86. doi: 10.5009/gnl15492.

引用本文的文献

1
Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis.多回波 Dixon 和 MRS 在定量肝脂肪含量和分期肝纤维化中的应用。
Sci Rep. 2023 Aug 2;13(1):12555. doi: 10.1038/s41598-023-39361-6.
2
Determination of Non-Invasive Biomarkers for the Assessment of Fibrosis, Steatosis and Hepatic Iron Overload by MR Image Analysis. A Pilot Study.通过磁共振图像分析确定用于评估纤维化、脂肪变性和肝铁过载的非侵入性生物标志物。一项初步研究。
Diagnostics (Basel). 2021 Jun 29;11(7):1178. doi: 10.3390/diagnostics11071178.
3
Multiparametric MR mapping in clinical decision-making for diffuse liver disease.
多参数磁共振成像在弥漫性肝病临床决策中的应用
Abdom Radiol (NY). 2020 Nov;45(11):3507-3522. doi: 10.1007/s00261-020-02684-3. Epub 2020 Aug 5.